According to a study presented at the American Heart Association’s Scientific Sessions 2015, patients with heart failure with preserved ejection fraction (HFpEF) did not have increased exercise ...

Please provide your email address to receive an email when new articles are posted on . ORLANDO, Fla. — Isosorbide mononitrate did not improve activity level, exercise capacity or quality of life of ...

Cilostazol and isosorbide mononitrate, two widely available drugs that have beneficial effects on endothelial function, appear to improve functional and cognitive outcomes when used in patients who ...

Isosorbide mononitrate is available in various formulations, including tablets, capsules, and solutions. The most commonly prescribed formulation is tablets. Isosorbide mononitrate is also available ...

DALLAS -- Drugs that improve endothelial function appeared promising for people with lacunar strokes resulting from small vessel disease (SVD), according to LACI-2 study findings that pave the way for ...

The information provided on this page is intended to serve as a comprehensive resource and should not be a substitute to professional medical advice. If you have concerns it is always best to speak ...

Isosorbide mononitrate is the active ingredient Elantan tablets (Nappi code: 793418-001, 003), Elantan LA capsules (Nappi code: 860115-003), Imdur CR tablets (Nappi code: 821500-007), Ismo tablets ...

The information provided on this page is intended to serve as a comprehensive resource and should not be a substitute to professional medical advice. If you have concerns it is always best to speak ...

Older patients with isolated systolic hypertension (ISH) who fail to respond to combined therapy with conventional antihypertensives should be given a long-acting nitrate preparation as adjunct ...

Zydus Lifesciences Limited’s shares went up 1.40 per cent after the company secured final approval from the United States Food and Drug Administration (USFDA) for the production and distribution of ...

Ahmedabad: Zydus Lifesciences Limited received final approval from the United States Food and Drug Administration (USFDA) to manufacture and market Isosorbide Mononitrate Extended-Release, Tablets USP ...